Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This study is a single-dose, parallel grouping, open-label phase I clinical study to evaluate the PK characteristics and safety of single subcutaneous injection of PB-119 in subjects with different degrees of renal insufficiency and matched subjects with normal renal function.
Epistemonikos ID: 8ff749b8ea17982e0bb50c137c02579886f41506
First added on: May 13, 2024